66. IgA腎症 IgA nephropathy Clinical trials / Disease details

臨床試験数 : 275 / 薬物数 : 258 - (DrugBank : 82) / 標的遺伝子数 : 36 - 標的パスウェイ数 : 140

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05174221 (ClinicalTrials.gov)	November 9, 2022	14/12/2021	A Study of Mezagitamabin Adults With Primary Immunoglobulin A Nephropathy Receiving Stable Backgroun ...	A Phase 1b, Multicenter, Open-Label Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Ef ...	Kidney Disease	Drug: Mezagitamab	Takeda	NULL	Recruiting	18 Years	N/A	All	16	Phase 1	United States;Australia;Belgium;China;Hungary;Italy;Japan;Korea, Republic of;Serbia;Singapore;Spain; ...
2	JPRN-jRCT2011220009	17/07/2022	15/06/2022	A Study of Mezagitamabin Adults With Primary Immunoglobulin A Nephropathy Receiving Stable Backgroun ...	A Phase 1b, Multicenter, Open-Label Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Ef ...	Kidney Disease	TAK-079 (Mezagitamab) Mezagitamab, subcutaneous injection, once weekly for 8 weeks then once every 2 ...	Nishizawa Atsushi	NULL	Recruiting	>= 18age old	Not applicable	Both	16	Phase 1	Australia;China;Spain;Italy;South Korea;Serbia;Singapore;Taiwan;USA;Belgium;Hungary;UK;Japan

First Previous1Next Last